首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
cholestatic cholangitis 相关文献:
New Treatment Paradigms in Primary Biliary Cholangitis.
Levy C, Manns M, Hirschfield G.
Clin Gastroenterol Hepatol. 2023 Jul;21(8):2076-2087. doi: 10.1016/j.cgh.2023.02.005. Epub 2023 Feb 19.
PMID:36809835
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
Sarcognato S, Sacchi D, Grillo F, Cazzagon N, Fabris L, Cadamuro M, Cataldo I, Covelli C, Mangia A, Guido M.
Pathologica. 2021 Jun;113(3):170-184. doi: 10.32074/1591-951X-245.
PMID:34294935
Primary biliary cholangitis: Epidemiology, prognosis, and treatment.
Trivella J, John BV, Levy C.
Hepatol Commun. 2023 Jun 2;7(6):e0179. doi: 10.1097/HC9.0000000000000179. eCollection 2023 Jun 1.
PMID:37267215
Primary sclerosing cholangitis.
Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M.
Lancet. 2018 Jun 23;391(10139):2547-2559. doi: 10.1016/S0140-6736(18)30300-3. Epub 2018 Feb 13.
PMID:29452711
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver.
J Hepatol. 2017 Jul;67(1):145-172. doi: 10.1016/j.jhep.2017.03.022. Epub 2017 Apr 18.
PMID:28427765
Diagnosis and Management of Primary Biliary Cholangitis.
Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, Jacobson IM.
Am J Gastroenterol. 2019 Jan;114(1):48-63. doi: 10.1038/s41395-018-0390-3.
PMID:30429590
Recent Advances in the Management of Primary Sclerosing Cholangitis.
Assis DN, Bowlus CL.
Clin Gastroenterol Hepatol. 2023 Jul;21(8):2065-2075. doi: 10.1016/j.cgh.2023.04.004. Epub 2023 Apr 19.
PMID:37084929
Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
Smith HT, de Souza AR, Thompson AH, McLaughlin MM, Dever JJ, Myers JA, Chen JV.
Dig Dis Sci. 2023 Jun;68(6):2710-2730. doi: 10.1007/s10620-023-07862-z. Epub 2023 Mar 18.
PMID:36933112
Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
Gui W, Hole MJ, Molinaro A, Edlund K, Jørgensen KK, Su H, Begher-Tibbe B, Gaßler N, Schneider CV, Muthukumarasamy U, Mohs A, Liao L, Jaeger J, Mertens CJ, Bergheim I, Strowig T, Hengstler JG, Hov JR, Marschall HU, Trautwein C, Schneider KM.
Nat Commun. 2023 Jun 6;14(1):3304. doi: 10.1038/s41467-023-38840-8.
PMID:37280200
Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?
Mayo MJ.
Hepatology. 2022 Aug;76(2):518-531. doi: 10.1002/hep.32405. Epub 2022 Mar 10.
PMID:35152430
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3